Bryan, Garnier & Co Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Bryan, Garnier & Co
Rating: 2.6
Author: MarketBeat

View the latest stock recommendations issued by analysts at Bryan, Garnier & Co. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Bryan, Garnier & Co's equity research team. MarketBeat is not affiliated with or endorsed by Bryan, Garnier & Co.

Updated 11/7/2024

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 0 Last 12 Months
Buy Ratings: 0 Last 12 Months
Sell Ratings: 0 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
MLTX MoonLake Immunotherapeutics	$18.42 +1.1%	9/14/2023		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/14/2023
TVTX Travere Therapeutics	$47.85 +8.0%	5/5/2023		Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2023
IMCR Immunocore	$28.55 -2.9%	3/24/2023		Initiated Coverage	$16.00	Buy	View details for Bryan, Garnier & Co rating of Immunocore (NASDAQ:IMCR) on 3/24/2023
IMTX Immatics	$11.39 +1.8%	3/24/2023		Initiated Coverage	$16.00	Buy	View details for Bryan, Garnier & Co rating of Immatics (NASDAQ:IMTX) on 3/24/2023
AUTL Autolus Therapeutics	$1.70 +0.9%	3/17/2023		Initiated Coverage	$5.00	Buy	View details for Bryan, Garnier & Co rating of Autolus Therapeutics (NASDAQ:AUTL) on 3/17/2023
CLLS Cellectis	$3.63 -1.1%	3/17/2023		Initiated Coverage	$6.00	Buy	View details for Bryan, Garnier & Co rating of Cellectis (NASDAQ:CLLS) on 3/17/2023
CRSP CRISPR Therapeutics	$53.51 +3.7%	3/17/2023		Initiated Coverage	$70.00	Buy	View details for Bryan, Garnier & Co rating of CRISPR Therapeutics (NASDAQ:CRSP) on 3/17/2023
MLTX MoonLake Immunotherapeutics	$18.42 +1.1%	2/2/2023		Initiated Coverage	$22.00	Buy	View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/2/2023
HXGBY Hexagon	SEK 10.91 +1.4%	12/14/2022		Initiated Coverage	SEK 100	Sell	View details for Bryan, Garnier & Co rating of Hexagon (OTCMKTS:HXGBY) on 12/14/2022
SAP SAP	€151.46 -2.0%	12/14/2022	Gregory Ramirez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	€130.00		View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 12/14/2022
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CRRFY Carrefour	€3.71 -4.6%	11/16/2022	Clement Genelot Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	€22.00 ➝ €20.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Carrefour (OTCMKTS:CRRFY) on 11/16/2022
TMSNY Temenos Group	CHF 82.52 -4.4%	10/17/2022	Gregory Ramirez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	CHF 118 ➝ CHF 58	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Temenos Group (OTCMKTS:TMSNY) on 10/17/2022
PHVS Pharvaris	$29.42 -1.6%	10/5/2022		Initiated Coverage	$16.00	Buy	View details for Bryan, Garnier & Co rating of Pharvaris (NASDAQ:PHVS) on 10/5/2022
TVTX Travere Therapeutics	$47.85 +8.0%	9/21/2022		Initiated Coverage	$17.00	Sell	View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2022
SGBAF SES	€10.96 +0.9%	9/20/2022	Thomas Coudry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	€6.50	Neutral	View details for Bryan, Garnier & Co rating of SES (OTCMKTS:SGBAF) on 9/20/2022
TAP Molson Coors Beverage	$41.87 +1.6%	9/1/2022	Nikolaas Faes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$54.00	Buy ➝ Sell	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 9/1/2022
ADRNY Ahold	€42.78 +1.5%	8/31/2022	Clement Genelot Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	€31.00 ➝ €34.00	Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Ahold (OTCMKTS:ADRNY) on 8/31/2022
ADYEY Adyen	$10.89 -3.4%	8/19/2022		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Adyen (OTCMKTS:ADYEY) on 8/19/2022
CMPGY Compass Group	$31.02 +1.0%	6/9/2022		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 6/9/2022
ZLNDY Zalando	€13.16 +1.7%	6/1/2022	Clement Genelot Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	€87.00 ➝ €38.00	Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 6/1/2022
GMAB Genmab A/S	DKK 26.74 -0.6%	5/13/2022	Victor Floch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 5/13/2022
NVO Novo Nordisk A/S	$44.59 +0.9%	5/5/2022		Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 5/5/2022
IPSEY IPSEN	$46.60 -0.7%	4/27/2022		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 4/27/2022
BLDR Builders FirstSource	$77.32 +3.9%	4/6/2022		Downgrade	$71.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Builders FirstSource (NYSE:BLDR) on 4/6/2022
HNNMY Hennes & Mauritz	SEK 3.50 +2.3%	4/4/2022	Cedric Rossi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	SEK 225 ➝ SEK 190	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Hennes & Mauritz (OTCMKTS:HNNMY) on 4/4/2022
DASTY Dassault Systemes	€23.08 -1.1%	3/25/2022	Gregory Ramirez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	€49.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 3/25/2022
MTLS Materialise	$6.31 +1.9%	3/25/2022	Gregory Ramirez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$20.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/25/2022
SDXAY Sodexo	€10.71 +0.3%	3/25/2022	Bruno De La Rochebrochard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	€95.00	Strong-Buy ➝ Buy	View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 3/25/2022
HESAY Hermes International	$190.60 +2.4%	3/18/2022		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Hermes International (OTCMKTS:HESAY) on 3/18/2022
TIIAY Telecom Italia	$8.41 -0.8%	3/14/2022	Thomas Coudry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Telecom Italia (OTCMKTS:TIIAY) on 3/14/2022
ZLNDY Zalando	$13.16 +1.7%	3/4/2022		Downgrade		Neutral	View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 3/4/2022
LKFT Lakefront Biotherapeutics American Depositary Shares	$27.71 +0.1%	1/28/2022		Upgrade		Sell ➝ Buy	View details for Bryan, Garnier & Co rating of Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) on 1/28/2022
NVS Novartis	$151.15 +0.2%	12/3/2021	Jeanjacques Le Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$115.00 ➝ $85.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 12/3/2021
AZN Astrazeneca	$185.79 -0.8%	11/22/2021		Downgrade		Buy	View details for Bryan, Garnier & Co rating of Astrazeneca (NYSE:AZN) on 11/22/2021
NVO Novo Nordisk A/S	DKK 44.59 +0.9%	11/3/2021	Jean-Jacques Le Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	DKK 148.00	Buy ➝ Sell	View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 11/3/2021
ESLOY EssilorLuxottica	$101.54 +1.3%	10/29/2021	Cedric Rossi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of EssilorLuxottica (OTCMKTS:ESLOY) on 10/29/2021
MTTRY Ceconomy	$0.63	10/12/2021	Clement Genelot Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Ceconomy (OTCMKTS:MTTRY) on 10/12/2021
BNTX BioNTech	$92.93 +0.7%	10/5/2021	Olga Smolentseva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$359.00		View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 10/5/2021
CODYY Compagnie de Saint-Gobain	€18.33 +2.1%	10/1/2021	Eric Lemaire Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	€80.00	Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 10/1/2021
BNTX BioNTech	$92.93 +0.7%	9/24/2021	Olga Smolentseva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$451.00		View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 9/24/2021
The REAL Reason Trump is Invading Iran (Ad) For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
VALN Valneva	$6.32 +4.4%	9/13/2021	Jean-Jacques Le Fur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Valneva (NASDAQ:VALN) on 9/13/2021
ERFSF Eurofins Scient	$74.05 +2.2%	8/25/2021	Bruno De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Strong-Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Eurofins Scient (OTCMKTS:ERFSF) on 8/25/2021
BNTX BioNTech	$92.93 +0.7%	8/11/2021	Olga Smolentseva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 8/11/2021
BOUYF Bouygues	$59.34	7/27/2021	Thomas Coudry Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	$37.20	Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Bouygues (OTCMKTS:BOUYF) on 7/27/2021
ERFSF Eurofins Scient	$74.05 +2.2%	7/9/2021	Bruno De Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Eurofins Scient (OTCMKTS:ERFSF) on 7/9/2021
LGRDY LeGrand	$34.92 -3.0%	6/29/2021	Eric Lemaire Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of LeGrand (OTCMKTS:LGRDY) on 6/29/2021
CODYY Compagnie de Saint-Gobain	$18.33 +2.1%	6/9/2021	Eric Lemaire Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 6/9/2021
MOR MorphoSys	$18.96	6/3/2021		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of MorphoSys (NASDAQ:MOR) on 6/3/2021
BNTX BioNTech	$92.93 +0.7%	5/17/2021		Reiterated Rating	$135.00 ➝ $206.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/17/2021
BAYRY Bayer Aktiengesellschaft	$11.00 +0.7%	5/13/2021		Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 5/13/2021
BNTX BioNTech	$92.93 +0.7%	5/11/2021		Downgrade	$135.00 ➝ $206.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/11/2021
BUD Anheuser-Busch InBev SA/NV	$83.93 +1.8%	5/6/2021		Upgrade		Sell ➝ Buy	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/6/2021
DBVT DBV Technologies	$18.51 +1.9%	5/3/2021		Upgrade		Sell ➝ Buy	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 5/3/2021
MTLS Materialise	$6.31 +1.9%	3/10/2021		Upgrade	$43.00	Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/10/2021
ECIFY Electricité de France	$2.55	2/24/2021		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Electricité de France (OTCMKTS:ECIFY) on 2/24/2021
BDRFY Beiersdorf Aktiengesellschaft	$17.02 +2.4%	2/17/2021		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFY) on 2/17/2021
IPHYF Innate Pharma	$1.65 -26.7%	2/9/2021		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Innate Pharma (OTCMKTS:IPHYF) on 2/9/2021
DASTY Dassault Systemes	$23.08 -1.1%	2/5/2021		Upgrade		Sell ➝ Buy	View details for Bryan, Garnier & Co rating of Dassault Systemes (OTCMKTS:DASTY) on 2/5/2021
SDXAY Sodexo	$10.71 +0.3%	2/3/2021		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Sodexo (OTCMKTS:SDXAY) on 2/3/2021
IFNNY Infineon Technologies	$89.19 -0.7%	1/14/2021		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 1/14/2021
VCISY Vinci	$36.38 +0.6%	1/14/2021		Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 1/14/2021
STM STMicroelectronics	$67.73 -4.2%	1/8/2021		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 1/8/2021
CODYY Compagnie de Saint-Gobain	$18.33 +2.1%	1/7/2021		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Compagnie de Saint-Gobain (OTCMKTS:CODYY) on 1/7/2021
LKFT Lakefront Biotherapeutics American Depositary Shares	$27.71 +0.1%	12/17/2020		Downgrade		Buy ➝ Sell	View details for Bryan, Garnier & Co rating of Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) on 12/17/2020
SCRYY Scor	$3.87	12/17/2020		Downgrade		Buy	View details for Bryan, Garnier & Co rating of Scor (OTCMKTS:SCRYY) on 12/17/2020
ITMPF Itm Power	$2.55 +3.7%	12/11/2020		Initiated Coverage		Buy	View details for Bryan, Garnier & Co rating of Itm Power (OTCMKTS:ITMPF) on 12/11/2020
STM STMicroelectronics	$67.73 -4.2%	12/10/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 12/10/2020
IPSEY IPSEN	$46.60 -0.7%	12/2/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of IPSEN (OTCMKTS:IPSEY) on 12/2/2020
BAYRY Bayer Aktiengesellschaft	$11.00 +0.7%	10/1/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) on 10/1/2020
GMAB Genmab A/S	$26.74 -0.6%	9/23/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 9/23/2020
IHG Intercontinental Hotels Group	$159.04 +3.1%	9/21/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Intercontinental Hotels Group (NYSE:IHG) on 9/21/2020
IPHA Innate Pharma	$1.77 +2.8%	9/9/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Innate Pharma (NASDAQ:IPHA) on 9/9/2020
DBVT DBV Technologies	$18.51 +1.9%	8/4/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 8/4/2020
BUD Anheuser-Busch InBev SA/NV	$83.93 +1.8%	7/15/2020		Downgrade		Buy ➝ Sell	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 7/15/2020
TAP Molson Coors Beverage	$41.87 +1.6%	7/15/2020		Upgrade	$49.00	Sell ➝ Buy	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/15/2020
DEO Diageo	$86.50 +1.7%	7/8/2020		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 7/8/2020
BNTX BioNTech	$92.93 +0.7%	7/2/2020		Boost Price Target	$50.00 ➝ $62.00		View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 7/2/2020
STM STMicroelectronics	$67.73 -4.2%	6/29/2020		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 6/29/2020
GMAB Genmab A/S	$26.74 -0.6%	6/3/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 6/3/2020
AZN AstraZeneca	£139.84 +0.2%	6/2/2020		Boost Price Target	GBX 8,780 ➝ GBX 9,100	Buy	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 6/2/2020
CGC Canopy Growth	$1.08 +2.4%	6/1/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020
AZN AstraZeneca	£139.84 +0.2%	5/11/2020		Boost Price Target	GBX 8,550 ➝ GBX 8,780	Buy	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 5/11/2020
DBVT DBV Technologies	$18.51 +1.9%	3/18/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 3/18/2020
SGE The Sage Group	GBX 855.24 -2.4%	3/2/2020		Lower Price Target	GBX 690 ➝ GBX 680	Neutral	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/2/2020
BUD Anheuser-Busch InBev SA/NV	$83.93 +1.8%	2/28/2020		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 2/28/2020
ACB Aurora Cannabis	$3.47 +0.1%	2/27/2020		Downgrade		Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Aurora Cannabis (NASDAQ:ACB) on 2/27/2020
GSK GSK	GBX 1,939.50 +0.8%	2/6/2020		Lower Price Target	GBX 1,800 ➝ GBX 1,773	Neutral	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 2/6/2020
SAP SAP	€151.46 -2.0%	1/28/2020		Set Price Target	€153.00	Buy	View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 1/28/2020
ASML ASML	$1,597.60 -2.1%	1/14/2020		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/14/2020
BRBY Burberry Group	GBX 1,167.36 +1.0%	1/10/2020		Boost Price Target	GBX 1,780 ➝ GBX 1,860	Neutral	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2020
I was right about SpaceX (Ad) Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day. See how to claim your stake in SpaceX before the public can
AZN AstraZeneca	£139.84 +0.2%	12/19/2019		Reiterated Rating		Buy	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/19/2019
GSK GSK	GBX 1,939.50 +0.8%	12/19/2019		Boost Price Target	GBX 1,660 ➝ GBX 1,747	Neutral	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 12/19/2019
AZN AstraZeneca	£139.84 +0.2%	11/25/2019		Upgrade	GBX 7,700 ➝ GBX 7,950	Buy	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/25/2019
CABGY Carlsberg AS	$27.81 +3.5%	8/12/2019		Upgrade		Neutral ➝ Buy	View details for Bryan, Garnier & Co rating of Carlsberg AS (OTCMKTS:CABGY) on 8/12/2019
TAP Molson Coors Beverage	$41.87 +1.6%	8/1/2019		Reiterated Rating	$51.00	Neutral ➝ Sell	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 8/1/2019
CGC Canopy Growth	$1.08 +2.4%	7/5/2019		Downgrade		Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 7/5/2019
WEED Canopy Growth	C$1.49 +2.8%	7/4/2019		Downgrade	C$85.00 ➝ C$60.00	Buy ➝ Neutral	View details for Bryan, Garnier & Co rating of Canopy Growth (TSE:WEED) on 7/4/2019
AZN AstraZeneca	£139.84 +0.2%	7/3/2019		Reiterated Rating		Neutral	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/3/2019
BRBY Burberry Group	GBX 1,167.36 +1.0%	5/20/2019		Upgrade		Neutral	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 5/20/2019
BURBY Burberry Group	$16.19 +2.8%	5/20/2019		Upgrade		Sell ➝ Neutral	View details for Bryan, Garnier & Co rating of Burberry Group (OTCMKTS:BURBY) on 5/20/2019

MarketBeat Community Rating for Bryan, Garnier & Co

MarketBeat's community ratings are surveys of what our community members think about Bryan, Garnier & Co and other research firms in the last 90 days. Vote "Outperform" if you believe Bryan, Garnier & Co's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Bryan, Garnier & Co's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES: 28 Believe will outperform the market
UNDERPERFORM VOTES: 26 Believe will underperform the market

Best & Worst Calls

Best Call
0000.0%
NASDAQ:MLTX
Initiated Coverage • Feb 2, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
OTCMKTS:NKLAQ
Initiated Coverage • May 16, 2024
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bryan, Garnier & Co Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Bryan, Garnier & Co

Best & Worst Calls

Similarly Rated Firms